Patients With Newly Diagnosed Hypertension Treated With the Renin Angiotensin Receptor Blocker Azilsartan Medoxomil vs Angiotensin‐Converting Enzyme Inhibitors: The Prospective EARLY Registry

Publisher： John Wiley & Sons Inc

E-ISSN： 1751-7176|17|12|947-953

ISSN： 1524-6175

Source： The Journal of Clinical Hypertension, Vol.17, Iss.12, 2015-12, pp. : 947-953

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative effectiveness of an angiotensin receptor blocker, olmesartan medoxomil, in older hypertensive patients

By  

The Journal of Clinical Hypertension, Vol. 20, Iss. 2, 2018-02 ,pp. : 356-365

John Wiley & Sons Inc

Access to resources Recommend Favorite

Severe Angioedema Associated With Angiotensin‐Converting Enzyme Inhibitor Therapy in Two Patients With Pollen‐Food Allergy Syndrome

By  

The Journal of Clinical Hypertension, Vol. 17, Iss. 6, 2015-06 ,pp. : 493-494

John Wiley & Sons Inc

Access to resources Recommend Favorite

Associations of Angiotensin‐Converting Enzyme Insertion/Deletion, Angiotensin II Receptor A1166C, and Endothelial Nitric Oxide Synthase 4b/a Gene Polymorphisms With Pregnancy Hypertensive Disorders: A Meta‐Analysis

By  

The Journal of Clinical Hypertension, Vol. 17, Iss. 12, 2015-12 ,pp. : 954-962

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sacubitril/valsartan instead of renin‐angiotensin system inhibition alone: A step forward in resistant hypertension

By  

The Journal of Clinical Hypertension, Vol. 20, Iss. 1, 2018-01 ,pp. : 65-68

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of Serum Uric Acid Level With Blood Pressure Variability in Newly Diagnosed Essential Hypertension

By  

The Journal of Clinical Hypertension, Vol. 17, Iss. 12, 2015-12 ,pp. : 929-935

John Wiley & Sons Inc

Access to resources Recommend Favorite